Overview

Oral Nitrite for Older Heart Failure With Preserved Ejection Fraction

Status:
Completed
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
This is a randomized double blinded controlled trial of 20-40 mg sodium nitrite tid in subjects with HFpEF. Primary outcomes are measures of physical function with non-invasive and invasive cardiopulmonary exercise testing, and fatigability, skeletal muscle bioenergetics, serology including inflammatory markers and platelet bioenergetics, quality of life measures.
Phase:
Phase 2
Details
Lead Sponsor:
Gladwin, Mark, MD
University of Pittsburgh
Collaborator:
National Institute on Aging (NIA)